seborrheic keratosis
Information
- Disease name
- seborrheic keratosis
- Disease ID
- DOID:6498
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05136144 | Active, not recruiting | Phase 2 | Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis | October 19, 2021 | July 31, 2024 |
| NCT01159860 | Completed | N/A | Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses? | July 2010 | June 6, 2013 |
| NCT01214564 | Completed | Phase 2 | Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis | October 2010 | December 2010 |
| NCT02160626 | Completed | Phase 2 | Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis | June 2014 | December 2014 |
| NCT02260180 | Completed | Phase 2 | Study of A-101 for the Treatment of Seborrheic Keratosis | October 2014 | March 2015 |
| NCT02667236 | Completed | Phase 3 | A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis. | January 2016 | October 2016 |
| NCT02667275 | Completed | Phase 3 | A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis | January 2016 | October 2016 |
| NCT02667288 | Completed | Phase 3 | An Open-Label Safety Study of A-101 Solution | January 2016 | October 2016 |
| NCT03148691 | Completed | Phase 2 | A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis | May 17, 2017 | April 3, 2018 |
| NCT03487588 | Completed | Phase 4 | An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses | March 21, 2018 | November 14, 2018 |
| NCT03846531 | Completed | N/A | Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study | May 4, 2017 | May 22, 2018 |
| NCT00540566 | Completed | Optical Biopsy of Human Skin in Conjunction With Laser Treatment | June 1999 | July 2008 | |
| NCT05353374 | Completed | N/A | Effectiveness of Sodium Fusidate Ointment Compared to Petrolatum for Wound Healing Following Cauterization | January 1, 2021 | May 31, 2021 |
| NCT06046144 | Completed | Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors | November 2, 2022 | May 1, 2023 | |
| NCT06108024 | Recruiting | Phase 2 | A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis | November 6, 2023 | October 15, 2024 |
| NCT04249115 | Terminated | N/A | Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study | February 5, 2019 | April 22, 2021 |
| NCT04688749 | Terminated | Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage | July 17, 2019 | December 31, 2022 | |
| NCT04229277 | Unknown status | N/A | Fast Track Diagnosis of Skin Cancer by Advanced Imaging | September 9, 2019 | June 1, 2021 |
- Disase is a (Disease Ontology)
- DOID:161
- Disase is a (Disease Ontology)
- DOID:174
- Cross Reference ID (Disease Ontology)
- GARD:3108
- Cross Reference ID (Disease Ontology)
- ICD10CM:L82
- Cross Reference ID (Disease Ontology)
- ICD9CM:702.1
- Cross Reference ID (Disease Ontology)
- MESH:D017492
- Cross Reference ID (Disease Ontology)
- MIM:182000
- Cross Reference ID (Disease Ontology)
- NCI:C9006
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:201096007
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0022603
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0031287